California AB536 mandates no cost-sharing for colorectal cancer screening tests approved by the FDA or recommended by the American Cancer Society or.

California AB536 amends the Health and Safety Code and the Insurance Code to ensure that health insurance policies and health care service plans provide coverage without cost-sharing for colorectal cancer screening tests. These tests must be approved by the FDA, meet the requirements of the federal Centers for Medicare and Medicaid Services, be included in the American Cancer Society guidelines, or receive a grade of A or B from the U.S. Preventive Services Task Force. The required colonoscopy for a positive result on a screening test must also be covered without cost-sharing.

California AB536 mandates no cost-sharing for colorectal cancer screening tests approved by the FDA or recommended by the American Cancer Society or.

California AB536 amends the Health and Safety Code and the Insurance Code to ensure that health insurance policies and health care service plans provide coverage without cost-sharing for colorectal cancer screening tests. These tests must be approved by the FDA, meet the requirements of the federal Centers for Medicare and Medicaid Services, be included in the American Cancer Society guidelines, or receive a grade of A or B from the U.S. Preventive Services Task Force. The required colonoscopy for a positive result on a screening test must also be covered without cost-sharing.